A PYMNTS Company

Global: UBS exec predicts optimistic M&A this year

By  |  January 29, 2014

The head of US mergers and acquisitions at UBS is championing his optimism this year for mergers and acquisitions, reports say.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Marc-Anthony Hourihan offered an interview in which the executive sees positive growth from M&A deals throughout the globe thanks to a more stable economy in Europe and boosted investment activity.

    Hourihan said he considers last year’s merger results to be “fairly good,” but the uncertainty within the EU economy hampered growing results. Further, the expert sees “real estate, technology and healthcare” will likely be the industries that see major acquisition deals in 2014.

    Hourihan has been with UBS for two decades and has advised on major deals including the $6.5 billion buyout of ImClone Systems by Eli Lilly.

    Full Content: MarketWatch

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.